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Summary A study of C3H mice implanted with mammary tumours has shown that the levels of serum total
protein, alanine transaminase and alkaline phosphatase are all lower than those found in normal mice, while
aspartate transaminase is higher. Serum urea values were similar to normal levels, but creatinine was lower in
males and higher in females. In the male mice, urine protein and urine N-acetyl-,B-D-glucosaminidase (NAG)
activity were lower than in normal mice.
Comparisons were made with age and sex matched controls which was found to be important for alkaline
phosphatase, as this was shown to decrease with increasing age of the mice over the period from 10-30 weeks
of age.
The analyte values found in this study provide useful base-line data for assessing biochemical toxicity of
cancer chemotherapy agents. It has been shown that some of these values can vary with age, or can be
different if tumour-bearing mice are used instead of normal mice.
There are some published biochemical data for
serum and urine analytes for normal mice
(Crispens, 1975), but none for tumour-bearing mice.
As these were being used in a study of platinum
drug toxicity (Laverick et al., 1985), it seemed
appropriate to establish baseline levels for both
normal and tumour-bearing mice.
Measurement of serum urea, serum and urine
creatinine, urine total protein and N-acetyl-fl-D-
glucosaminidase (NAG), a renal tubular lysosomal
hydrolase and a sensitive indicator of tubular
damage, were made for the assessment of nephro-
toxicity, and total protein, aspartate and alanine
transaminase, and alkaline phosphatase for liver
damage.
The values that were obtained for the tumour-
bearing mice were compared with those for age and
sex matched normal controls which were studied
over a period from the age of 10-30 weeks.
Materials and methods
Animals
Normal mice (SPF derived C3H/He/GB-Sth(2SMq))
up to the age of 30 weeks were used, also similar
mice in which tumours had been grown. In the
latter the mice had been transplanted at 12 weeks
with C3H mouse mammary adenocarcinoma ac-
cording to the method described by Tozer et al.
(1984). The mice were sacrificed 15 days after the
tumour first became palpable by which time the
tumours had grown to the maximun acceptable size
(at - 15 weeks of age).
Blood collection
For these studies mice were anaesthetized with
Sagatal (Pentobarbitone sodium 60mgml-1)
supplied by May and Baker Ltd., Dagenham, using
a lethal dose of 3 mg. The chest was opened, and
blood allowed to flow into the chest cavity from
where it was aspirated with a syringe without a
needle. The blood was transferred to a glass tube
and allowed to clot, centrifuged at 3,000 rpm for
Omin, after which the serum was removed and
stored at -20°C until assayed. This procedure was
found to be preferable to the more usual procedure
of cervical dislocation and aspiration of blood from
the heart, a technique that yielded a smaller
amount of serum which was sometimes haemolysed.
Blood was collected from the tumour-bearing
mice (10 male and 10 female), and also from
normal mice (15 male and 15 female in each age
group) aged 10, 15, 20, 25 and 30 weeks. The blood
from two or three mice was pooled, several pools
being obtained for each age and sex group. Suffici-
ent serum was obtained for each pooled blood
sample to be analysed in duplicate so that precision
studies could be performed.
Urine collection
Urine was obtained from the tumour-bearing mice
and from each of the 15 male and 15 female mice
in each age group prior to anesthesia, with manual
expression where necessary. Urine samples were
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pooled in a similar way to the blood samples, the
pooled samples being analysed in duplicate, having
been stored at -20°C until assayed.
Analytical methods
The analytical methods used were those currently in
use in the chemical pathology department of this
hospital for routine assays of human serum and
urine. It was necessary to make minor adaptations
to accommodate the smaller volumes of specimens
available, and the different analyte concentration or
enzyme activity found in mouse serum and urine.
Appendix I lists the techniques used, volumes of
serum or urine required, instrumentation and
analytical conditions, and a reference to the source
of the method. In this study on mice where it has
been impossible to collect timed urine specimens,
the urine NAG activity and protein excretion have
been expressed as a ratio of urinary creatinine.
Statistical analysis
Results were presented as mean +1 standard
deviation, and analysed for their statistical signifi-
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Results of precision for each method are shown
in Appendix I.
Results
Valuesfor serum and urine analytesfor normal male
andfemale mice ofdifferent ages
The serum and urine analyte values for each age
group of normal male and female mice are plotted
in Figures 1 and 2 (mean + 1 sd). Mean values are
shown for 10-20 week-old mice (B) (the age group
for most of the intended platinum studies) and for
the 25-30 week age group (C) to assess the effect of
increasing age. The overall mean (A), shows
whether there was any need for using age related
values for reference.
Sex difference
No significant difference was found between normal
male and female mice for serum urea, creatinine,
Male
Age (days)
A B C TB 80 120 160 200
{{f ]I W4
I
f i a
I
i{
N
10 15 20 25 30
Age (weeks)
A B C TB
{ I
3
i i
i i- i f I'
{
I I
_ _ __ _ __ _ __ _ __ _ __ _ _
10 15 20 25 30
Age (weeks)
Figure 1 Mean values (±sd) obtained for serum analytes from mice of different age groups (10-30 weeks)
shown individually, and also with the mean values overall (A); 10-20 week old mice (B) 25-30 week old mice
(C) and tumour-bearing mice (TB).
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Figure 1 Mean values (±sd) obtained for serum analytes from mice of different age groups (10-30 weeks)
shown individually, and also with the mean values overall (A); 10-20 week old mice (B); 25-39 week old mice
(C) and tumour-bearing mice (TB).
total protein or the alanine transaminases (Figure
1). Aspartate transaminase was higher in females
when considered for the 10-20 week age group and
on an overall basis (P<0.01 in both cases), but was
not apparent for the older aged mice. Alkaline
phosphatase also showed sex differences, the female
values being higher than males when considered for
all mice or in the two separate age groups (P<0.05,
P<0.001 and P<0.001 respectively).
Urine NAG and protein (Figure 2), showed
higher levels from males (P<0.001 in all instances),
but there were no differences for creatinine.
Effect ofincreasing age
There were no significant differences between
different age groups for either of the transaminases
or for total serum protein (Figure 1). However,
there was a lower value for urea in the 25-30 week
old male mice, the mean being significantly
different from the 10-20 week mean (P<0.001).
The female mice had a lower serum creatinine for
the 25-30 week age group which was significantly
different from the overall mean (P<0.01) and from
the 10-20 week mean (P<0.001).
As the age of the mice increased the level of
alkaline phosphatase activity was found to decrease
for both sexes, there was a significant difference
(Figure 1) for the males between the overall mean
and the 10-20 week and 25-30 week mean, and
between the 10-20 week and 25-30 week mean
(P<0.01, P<0.001 and P<0.001 respectively). For
the females, despite the obvious aging effect, the
difference between the overall mean and the 10-20
week mean was not significant, but was significant
when compared with the 25-30 week age group
(P<0.001).
Urine protein did not change significantly with
increasing age, but there were some minor changes
in urine creatinine in the female mice (Figure 2),
that at 10-20 weeks being significantly higher than
the 25-30 week mean (P<0.01). The urine NAG
related to creatinine showed some decrease with age
in the males (P<0.02) while that in females
appeared to increase (P<0.001), which may have
been affected by the lower urine creatinine in this
age group.
Tumour-bearing mice
The range of values for the analytes of tumour-
bearing mice are also shown in Figures 1 and 2
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(TB). The tumour-bearing mice had urea values
that were not statistically different from those of
comparable aged normal mice (10-20 week) Figure
1(B), but there were significant decreases for
alanine transaminase, alkaline phosphatase and
total serum protein (P<0.001 in all cases). The sex
difference with alkaline phosphatase was the reverse
to that found in normal mice, in that the females
had a significantly lower level, the mean value
being only 30% of the normal level. Aspartate
transaminase showed some increase in both males
and females (P<0.001) Figure 1(B), the female
level being significantly higher than the male as was
the case with normal mice (P<0.001). The serum
creatinine increased in females (P<0.01) and
decreased in males (P<0.01) with a significantly
higher level in the females compared with the males
(P<0.001).
The urine creatinine showed no change when the
level in tumour-bearing mice is compared with that
for normal mice, but the males had lower levels of
urine NAG (P<0.05) and total protein (P<0.001)
when related to creatinine, there being no
significant change in the females (Figure 2).
Discussion
The most significant age related change found was
that for alkaline phosphatase, where the enzyme
activity decreased with increasing age (Figure 1).
Heat stability and electrophoretic studies have
demonstrated the presence of mainly bone phos-
phatase with a minor liver component in serum of
10 week and 25 week old male and female non-
tumour-bearing mice (Kind, unpublished data).
The decrease in alkaline phosphatase level may
therefore be partly due to a decrease in active bone
growth as the mouse matures at - 14 weeks. This is
similar to that found in humans during adolescence
as the epiphyses are closing. Although the mice
used in this study were at least 10 weeks of age and
therefore regarded as 'young adults', some residual
growth is known to occur thereafter. A higher level
was found in female mice. In man, there is no
reported significant sex difference.
The lower level of alkaline phosphatase activity
found in the tumour-bearing mice compared with
the comparable 10-20 week age group was an
interesting finding. The effect of the tumour-bearing
may be similar to the changes found with increasing
age, or possibly some suppression of osteoblastic
activity.
The tumour-bearing mice showed an increase in
aspartate transaminase activity which may be
related to a minor toxic effect of the tumour on red
cells or on hepatocytes with release of the enzyme.
However, these changes were not apparent with
alanine transaminase where the activity was
decreased in both sexes. In normal mice there was a
significant difference between the male and female
aspartate transaminase level; the lower level in the
males being more apparent in the 10-20 age group.
It is possible that the aspartate transaminase in the
tumour-bearing mice could have decreased in the
same way as the alanine transaminase, this being
masked by a supraimposed rise due to toxic effects.
In humans, the alanine transaminase is a more
sensitive index of liver damage, but it may not be
so in mice. In the normal mice, alanine trans-
aminase showed no significant sex or age
differences.
Total serum protein values showed no significant
differences in normal mice, but the tumour-bearing
group had significantly lower levels which, when
considered with the lower alkaline phosphatase and
alanine transaminase, may be an indication of
suppression of cell protein synthesis, although no
significant weight loss was observed.
Urine protein concentration was markedly higher
in male mice, but there was no difference with
increasing age in either sex. With the male tumour-
bearing mice, urine protein excretion was decreased,
and may again suggest reduced synthesis, possibly
of the prealbumin 'sex' protein.
The male mice, both normal and tumour-bearing
had much higher levels of urinary NAG activity
than the females, decreasing a little with age for the
males, but increasing for the females. There was
however, little evidence for a decrease in urine
NAG activity in the tumour-bearing mice, and it is
possible that the suggested superimposed toxic
effect that the tumour may have on aspartate
transaminase activity could also occur with NAG.
Where comparisons were possible, the results
obtained in this study were similar to published
data for some constituents (Crispens, 1975), while
in others there were quite marked differences. The
serum creatinine ranges were considerably lower
than the quoted value, and while urea was higher
than published values, total protein values were
similar. The enzymes were not so easy to compare
due to different techniques and assay conditions;
however the quoted range for alkaline phosphatase,
(no age or sex given), was similar but a little lower
than that found here.
The agreement between published results and
those found in this study was best for urine protein.
When the results were considered in terms of con-
centration (gl-1), rather than related to creatinine,
the value for males compared well with the pub-
lished range; however, for the females our mean
was approximately half the quoted range (Crispens,
1975). It is possible that the dye binding technique
used in our study was more sensitive and
contributed to this difference. Lacher et al. (1979)MOUSE MAMMARY TUMOUR AND SERUM & URINE ANALYTES 611
used an immunological technique, with antisera
raised against mouse serum proteins, but did not
comment on the much lower levels found in their
study compared with other published data.
If pathological biochemical changes are being
assessed in any situation, it is important to ensure
that the blood and urine samples are treated in an
identical manner to those specimens obtained for
the reference ranges, (especially with respect to
storage and to sample dilutions), and that the same
analytical techniques should be used. Only if this is
done can valid comparisons be made between
pathological and reference range results, a
procedure that we adopted for our platinum drug
study (Laverick et al., 1985). Furthermore, because
of the differences found here with the tumour-
bearing mice, we found it important that the
biochemical toxicity of chemotherapy drugs be
tested in tumour-bearing as well as normal mice,
thereby relating the study to the situation in which
these drugs will be used.
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